UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Aspirin and clopidogrel resistance: an emerging clinical entity

European heart journal, 2006-03, Vol.27 (6), p.647-654

2006

Volltextzugriff (PDF)

Clinical Aspects of Platelet Inhibitors and Thrombus Formation

Circulation research, 2007-05, Vol.100 (9), p.1261-1275

2007

Volltextzugriff (PDF)

The year in cardiovascular medicine 2021: diabetes and metabolic disorders

European heart journal, 2022-01, Vol.43 (4), p.263-270

2022

Volltextzugriff (PDF)

Virtual and Augmented Reality in Cardiovascular Care: State-of-the-Art and Future Perspectives

JACC. Cardiovascular imaging, 2022-03, Vol.15 (3), p.519-532

2022

Volltextzugriff (PDF)

Semaglutide and cardiovascular outcomes by baseline HbA1c in diabetes: the SUSTAIN 6 and PIONEER 6 trials

European heart journal, 2024-04, Vol.45 (15), p.1371-1374

2024

Volltextzugriff (PDF)

Time to Benefit With Sotagliflozin in Patients With Worsening Heart Failure

Journal of the American College of Cardiology, 2023-04, Vol.81 (15), p.1546-1549

2023

Volltextzugriff (PDF)

Predicting survival and neurological outcome in out-of-hospital cardiac arrest using machine learning: the SCARS model

EBioMedicine, 2023-03, Vol.89, p.104464-104464, Article 104464

2023

Volltextzugriff (PDF)

Scientific and therapeutic advances in antiplatelet therapy

Nature reviews. Drug discovery, 2003-01, Vol.2 (1), p.15-28

2003

Volltextzugriff (PDF)

Aldosterone and aldosterone synthase inhibitors in cardiorenal disease

American journal of physiology. Heart and circulatory physiology, 2024-03, Vol.326 (3), p.H670-H688

2024

Volltextzugriff (PDF)

Aspirin resistance: more than just a laboratory curiosity

Journal of the American College of Cardiology, 2004-03, Vol.43 (6), p.1127-1129

Bhatt, Deepak L

2004

Volltextzugriff (PDF)

Potential for residual cardiovascular risk reduction: Eligibility for icosapent ethyl in the VERTIS CV population with type 2 diabetes and atherosclerotic cardiovascular disease

Diabetes, obesity & metabolism, 2023-05, Vol.25 (5), p.1398-1402

2023

Volltextzugriff (PDF)

Analysis of Risk of Bleeding Complications After Different Doses of Aspirin in 192,036 Patients Enrolled in 31 Randomized Controlled Trials

The American journal of cardiology, 2005-05, Vol.95 (10), p.1218-1222

2005

Volltextzugriff (PDF)

Does creatinine kinase-MB elevation after percutaneous coronary intervention predict outcomes in 2005? Periprocedural cardiac enzyme elevation predicts adverse outcomes

Circulation (New York, N.Y.), 2005-08, Vol.112 (6), p.906-15; discussion 923

2005

Volltextzugriff (PDF)

The Cost-Effectiveness of Rivaroxaban Plus Aspirin Compared with Aspirin Alone in the COMPASS Trial: A US Perspective

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2024-01, Vol.24 (1), p.117-127

2024

Volltextzugriff (PDF)

Streamlining cardiovascular clinical trials to improve efficiency and generalisability

Heart (British Cardiac Society), 2017-08, Vol.103 (15), p.1156-1162

2017

Volltextzugriff (PDF)

Increased mortality with oral platelet glycoprotein IIb/IIIa antagonists : A meta-analysis of phase III multicenter randomized trials

Circulation (New York, N.Y.), 2001-01, Vol.103 (2), p.201-206

2001

Volltextzugriff (PDF)

Definitions of peri-procedural myocardial infarction and the association with one-year mortality: Insights from CHAMPION trials

International journal of cardiology, 2018-11, Vol.270, p.96-101

2018

Volltextzugriff (PDF)

Current role of platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes

JAMA : the journal of the American Medical Association, 2000-09, Vol.284 (12), p.1549

2000

Volltextzugriff (PDF)

Benefit of clopidogrel over aspirin is amplified in patients with a history of ischemic events

Stroke (1970), 2004-02, Vol.35 (2), p.528-532

2004

Volltextzugriff (PDF)

Platelet glycoprotein IIb/IIIa inhibitors reduce mortality in diabetic patients with non-ST-segment-elevation acute coronary syndromes

Circulation (New York, N.Y.), 2001-12, Vol.104 (23), p.2767-2771

2001

Volltextzugriff (PDF)

Need to test the arterial inflammation hypothesis

Circulation (New York, N.Y.), 2002-07, Vol.106 (1), p.136-140

2002

Volltextzugriff (PDF)

Meta-analysis of randomized and registry comparisons of ticlopidine with clopidogrel after stenting

Journal of the American College of Cardiology, 2002-01, Vol.39 (1), p.9-14

2002

Volltextzugriff (PDF)

To cath or not to cath: that is no longer the question

JAMA : the journal of the American Medical Association, 2005-06, Vol.293 (23), p.2935

Bhatt, Deepak L

2005

Volltextzugriff (PDF)

Long-Term Treatment with the Combination of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease: Outcomes During the Open Label Extension of the COMPASS trial

European heart journal. Cardiovascular pharmacotherapy, 2022-12, Vol.8 (8), p.786-795

2022

Volltextzugriff (PDF)

1 – 25 von 80

Suche als RSS-Feed

Aktive Filter

ThemaMiddle Aged

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(73)
Mit Volltextzugriff
(69)

Publikationsform

Artikel
(80)

Sprache

Englisch
(79)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(77)
Science & Technology
(77)
Cardiovascular System & Cardiology
(52)
Cardiac & Cardiovascular Systems
(46)
Biological And Medical Sciences
(31)
Medical Sciences
(31)
Platelet Aggregation Inhibitors - Therapeutic Use
(27)
Male
(22)
Female
(21)
Treatment Outcome
(18)
Aspirin - Therapeutic Use
(16)
Peripheral Vascular Disease
(16)
Ticlopidine - Analogs & Derivatives
(16)
Risk Factors
(15)
Ticlopidine - Therapeutic Use
(15)
Aspirin
(14)
Randomized Controlled Trials As Topic
(14)
Aged
(13)
Clopidogrel
(13)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Aspirin and clopidogrel resistance: an emerging clinical entity

Clinical Aspects of Platelet Inhibitors and Thrombus Formation

The year in cardiovascular medicine 2021: diabetes and metabolic disorders

Virtual and Augmented Reality in Cardiovascular Care: State-of-the-Art and Future Perspectives

Semaglutide and cardiovascular outcomes by baseline HbA1c in diabetes: the SUSTAIN 6 and PIONEER 6 trials

Time to Benefit With Sotagliflozin in Patients With Worsening Heart Failure

Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: the updated SMART2 algorithm

Predicting survival and neurological outcome in out-of-hospital cardiac arrest using machine learning: the SCARS model

Scientific and therapeutic advances in antiplatelet therapy

Aldosterone and aldosterone synthase inhibitors in cardiorenal disease

Aspirin resistance: more than just a laboratory curiosity

Potential for residual cardiovascular risk reduction: Eligibility for icosapent ethyl in the VERTIS CV population with type 2 diabetes and atherosclerotic cardiovascular disease

Analysis of Risk of Bleeding Complications After Different Doses of Aspirin in 192,036 Patients Enrolled in 31 Randomized Controlled Trials

Does creatinine kinase-MB elevation after percutaneous coronary intervention predict outcomes in 2005? Periprocedural cardiac enzyme elevation predicts adverse outcomes

The Cost-Effectiveness of Rivaroxaban Plus Aspirin Compared with Aspirin Alone in the COMPASS Trial: A US Perspective

Streamlining cardiovascular clinical trials to improve efficiency and generalisability

Increased mortality with oral platelet glycoprotein IIb/IIIa antagonists : A meta-analysis of phase III multicenter randomized trials

Definitions of peri-procedural myocardial infarction and the association with one-year mortality: Insights from CHAMPION trials

Current role of platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes

Benefit of clopidogrel over aspirin is amplified in patients with a history of ischemic events

Platelet glycoprotein IIb/IIIa inhibitors reduce mortality in diabetic patients with non-ST-segment-elevation acute coronary syndromes

Need to test the arterial inflammation hypothesis

Meta-analysis of randomized and registry comparisons of ticlopidine with clopidogrel after stenting

To cath or not to cath: that is no longer the question

Long-Term Treatment with the Combination of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease: Outcomes During the Open Label Extension of the COMPASS trial

Aktive Filter

Suchergebnisse filtern